×

Eli Lilly stopped development of heart drug

9:00 AM ET Mon, 12 Oct 2015

Eli Lilly stopped the development of its heart drug, evacetrapib, as the treatment was not found effective enough in a late-stage trial, sending its shares down nearly 10 percent in premarket trading.